Association Between Early Lactate Levels and 30-Day Mortality in Clinically Suspected Sepsis in Children

被引:106
|
作者
Scott, Halden F. [1 ,2 ]
Brou, Lina [1 ]
Deakyne, Sara J. [3 ]
Kempe, Allison [1 ,3 ,4 ]
Fairclough, Diane L. [4 ,5 ]
Bajaj, Lalit [1 ,2 ]
机构
[1] Univ Colorado, Dept Pediat, Aurora, CO USA
[2] Childrens Hosp Colorado, Dept Pediat, Sect Emergency Med, Aurora, CO USA
[3] Childrens Hosp Colorado, Dept Pediat, Aurora, CO USA
[4] Univ Colorado, Adult & Child Ctr Outcomes Res & Delivery Sci, Aurora, CO USA
[5] Colorado Sch Publ Hlth, Aurora, CO USA
关键词
INTERNATIONAL CONSENSUS DEFINITIONS; SEPTIC SHOCK; EMERGENCY-DEPARTMENT; SERUM LACTATE; RESUSCITATION BUNDLE; ORGAN DYSFUNCTION; CLEARANCE; PREDICTOR; MANAGEMENT; ADHERENCE;
D O I
10.1001/jamapediatrics.2016.3681
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
IMPORTANCE Improving emergency care of pediatric sepsis is a public health priority, but optimal early diagnostic approaches are unclear. Measurement of lactate levels is associated with improved outcomes in adult septic shock, but pediatric guidelines do not endorse its use, in part because the association between early lactate levels and mortality is unknown in pediatric sepsis. OBJECTIVE To determine whether the initial serum lactate level is associated with 30-day mortality in children with suspected sepsis. DESIGN, SETTING, AND PARTICIPANTS This observational cohort study of a clinical registry of pediatric patients with suspected sepsis in the emergency department of a tertiary children's hospital from April 1, 2012, to December 31, 2015, tested the hypothesis that a serum lactate level of greater than 36mg/dL is associated with increased mortality compared with a serum lactate level of 36mg/dL or less. Consecutive patients with sepsis were identified and included in the registry following consensus guidelines for clinical recognition (infection and decreased mental status or perfusion). Among 2520 registry visits, 1221 were excluded for transfer from another medical center, no measurement of lactate levels, and patients younger than 61 days or 18 years or older, leaving 1299 visits available for analysis. Lactate testing is prepopulated in the institutional sepsis order set but may be canceled at clinical discretion. EXPOSURES Venous lactate level of greater than 36mg/dL on the first measurement within the first 8 hours after arrival. MAIN OUTCOMES AND MEASURES Thirty-day in-hospital mortality was the primary outcome. Odds ratios were calculated using logistic regression to account for potential confounders. RESULTS Of the 1299 patients included in the analysis (753 boys [58.0%] and 546 girls [42.0%]; mean [SD] age, 7.3 [5.3] years), 899 (69.2%) had chronic medical conditions and 367 (28.3%) had acute organ dysfunction. Thirty-day mortality occurred in 5 of 103 patients (4.8%) with lactate levels greater than 36mg/dL and 20 of 1196 patients (1.7%) with lactate levels of 36mg/dL or less. Initial lactate levels of greater than 36mg/dL were significantly associated with 30-day mortality in unadjusted (odds ratio, 3.00; 95% CI, 1.10-8.17) and adjusted (odds ratio, 3.26; 95% CI, 1.16-9.16) analyses. The sensitivity of lactate levels greater than 36mg/dL for 30-day mortality was 20.0% (95% CI, 8.9%-39.1%), and specificity was 92.3% (90.7%-93.7%). CONCLUSIONS AND RELEVANCE In children treated for sepsis in the emergency department, lactate levels greater than 36mg/dL were associated with mortality but had a low sensitivity. Measurement of lactate levels may have utility in early risk stratification of pediatric sepsis.
引用
收藏
页码:249 / 255
页数:7
相关论文
共 50 条
  • [1] Association between Lactate Dehydrogenase and 30-Day Mortality in Patients with Sepsis: a Retrospective Cohort Study
    Liu, Zhengting
    Liu, Feng
    Liu, Cong
    Chen, Xianchun
    CLINICAL LABORATORY, 2023, 69 (06) : 1195 - 1202
  • [2] Venous vs Arterial Lactate and 30-Day Mortality in Pediatric Sepsis Reply
    Scott, Halden F.
    Kempe, Allison
    Bajaj, Lalit
    JAMA PEDIATRICS, 2017, 171 (08) : 813 - 814
  • [3] Association between blood urea nitrogen and 30-day mortality in patients with sepsis: a retrospective analysis
    Li, Xu
    Zheng, Ruixia
    Zhang, Tian
    Zeng, Zhaotao
    Li, Haifeng
    Liu, Jiaming
    ANNALS OF PALLIATIVE MEDICINE, 2021, 10 (11) : 11653 - 11663
  • [4] COMPARING THE CLINICAL UTILITY OF 30-DAY MORTALITY RISK STRATIFICATION TOOLS IN SUSPECTED SEPSIS
    Chou, Shih-Hsiung
    Kowalkowski, Marc
    McWilliams, Andrew
    Evans, Susan
    Taylor, Brice
    McCurdy, Lewis
    Russo, Mark
    Runyon, Michael
    Heffner, Alan
    Murphy, Stephanie
    Rossman, Whitney
    Michael, Gibbs
    Cunningham, Kyle
    Taylor, Stephanie
    CRITICAL CARE MEDICINE, 2019, 47
  • [5] Association between early serum cholinesterase activity and 30-day mortality in sepsis-3 patients: A retrospective cohort study
    Peng, Zheng-Liang
    Huang, Liang-Wei
    Yin, Jian
    Zhang, Ke-Na
    Xiao, Kang
    Qing, Guo-Zhong
    PLOS ONE, 2018, 13 (08):
  • [6] Lactate as a Predictor of 30-Day Mortality in Cardiogenic Shock
    Klemm, Gregor
    Markart, Sebastian
    Hermann, Alexander
    Staudinger, Thomas
    Hengstenberg, Christian
    Heinz, Gottfried
    Zilberszac, Robert
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (07)
  • [7] The association between autoimmune disease and 30-day mortality among sepsis ICU patients: a cohort study
    Mallory Sheth
    Corey M. Benedum
    Leo Anthony Celi
    Roger G. Mark
    Natasha Markuzon
    Critical Care, 23
  • [8] The association between autoimmune disease and 30-day mortality among sepsis ICU patients: a cohort study
    Sheth, Mallory
    Benedum, Corey M.
    Celi, Leo Anthony
    Mark, Roger G.
    Markuzon, Natasha
    CRITICAL CARE, 2019, 23 (1)
  • [9] The association between serum magnesium levels and community-acquired pneumonia 30-day mortality
    Nasser, Roni
    Naffaa, Mohammad E.
    Mashiach, Tanya
    Azzam, Zaher S.
    Braun, Eyal
    BMC INFECTIOUS DISEASES, 2018, 18
  • [10] The association between serum magnesium levels and community-acquired pneumonia 30-day mortality
    Roni Nasser
    Mohammad E. Naffaa
    Tanya Mashiach
    Zaher S. Azzam
    Eyal Braun
    BMC Infectious Diseases, 18